Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancerAmanda E.D. Van Swearingen, Carey K. Anders, Maria J. Sambade et al.|Neuro-Oncology|2017Cited by 42
Changing Natural History of HER2–Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted TherapiesLouisa A. Mounsey, Carey K. Anders, Elizabeth Claire Dees et al.|Clinical Breast Cancer|2017Cited by 42
A changing natural history of HER2-positive breast cancer metastatic to the brain in the era of new, targeted therapies.Louisa A. Mounsey, Carey K. Anders, Matthew G. Ewend et al.|Journal of Clinical Oncology|2016Cited by 4